Find clinical trials for Prostate Cancer in Pittsburgh, PA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Prostate Cancer trials near Pittsburgh, PA, USA:
pharmacokinetic (PK), pharmacodynamic (PD), and the preliminary efficacy of JANX007 in adults with metastatic castration-resistant prostate ...
Phase 1
Pittsburgh, Pennsylvania, United States and 25 other locations
The purpose of this study is to evaluate the effectiveness of CAN-2409 immunotherapy in patients undergoing active surveillance for localized prostate...
Phase 2
Pittsburgh, Pennsylvania, United States and 22 other locations
A Phase 1/2 study to evaluate the safety and efficacy of ARV-766 given by mouth alone or in combination with abiraterone in men with metastatic prostate...
Phase 1, Phase 2
Pittsburgh, Pennsylvania, United States and 22 other locations
The overall aim of the trial is to evaluate the safety, tolerability, and pharmacokinetics (PK) of AMG 509 (monotherapy and in combination with abira...
Phase 1
Pittsburgh, Pennsylvania, United States and 54 other locations
with prostate cancer who received at least one dose of AAA617 from interventional, Phase I-IV Novartis sponsored clinical trials....
Phase 4
Pittsburgh, Pennsylvania, United States and 53 other locations
the SpaceOAR Vue System in reducing late gastrointestinal (GI) toxicity in subjects undergoing Stereotactic Body Radiotherapy (SBRT) to treat prostate...
Pittsburgh, Pennsylvania, United States and 29 other locations
(control) in participants with metastatic Castration Resistant Prostate Cancer (mCRPC) with prior exposure to at least 1 Androgen R...
Phase 2
Pittsburgh, Pennsylvania, United States and 11 other locations
with high-risk and very high-risk localised/locally advanced prostate cancer with a breast cancer gene mutation (BRCAm)....
Phase 3
Pittsburgh, Pennsylvania, United States and 194 other locations
has in treatment of patients with metastatic castrate resistant prostate cancer (mCRPC).The hypothesis for this trial is that caboz...
Phase 2
Pittsburgh, Pennsylvania, United States and 3 other locations
therapy in participants with metastatic castration resistant prostate cancer (mCRPC). There will be ten cohorts in this study: Coho...
Phase 1, Phase 2
Pittsburgh, Pennsylvania, United States and 23 other locations
Clinical trials
Research sites
Resources
Legal